Isolation of Cells From Biopsy Tissue to Aid in Kidney Repair
Status and phase
Conditions
Treatments
Details and patient eligibility
About
Endothelial progenitor cells that reside in renal vasculature may be stimulated to initiate differentiation programs during episodes of injury. It is hypothesized that endothelial progenitor cells resident in the kidney can transition to a post-injury phenotype that promotes endothelial repair.
Full description
Endothelial dysfunction is central to the pathophysiology of vascular ischemia, bacterial sepsis, toxin-induced thrombotic microangiopathy, and antibody-mediated kidney transplant rejection and often manifest with renal failure. With each of these diagnoses circulating components of the complement cascade bind to endothelial cells and induce disease progression through anaphylactic cellular messaging, monocyte homing, and direct cell membrane disruption. In response to injury during embryologic development avascular metanephric blastema initiate endothelial differentiation. Although circulating hematopoietic progenitor cells have shown therapeutic promise they incorporate into renal vasculature at very low density.
Sex
Ages
Volunteers
Inclusion criteria
- Only patients who have a clinical indication for kidney biopsy will be considered.
- All subjects will be at least 18 years of age and may be of any gender.
- Patients undergoing a native or kidney transplant biopsy will be considered.
Exclusion criteria
- Patients not undergoing a kidney biopsy will be excluded.
Trial design
Primary purpose
Allocation
Interventional model
Masking
0 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal